Single-nodule hepatitis B virus-associated hepatocellular carcinoma smaller than 3 cm: two phenotypes defined by cluster analysis and their association with the outcome of ablation as the first-line therapy

References

• Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62(1):10–29.
   PubMed Web of Science ®Google Scholar
• Zhang B, Zhang B, Zhang Z, et al. 42,573 cases of hepatectomy in China: a multicenter retrospective investigation. Sci China Life Sci. 2018;61(6):660–670.
   PubMed Web of Science ®Google Scholar
• Heimbach JK, Kulik LM, Finn RS, et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358–380.
   PubMed Web of Science ®Google Scholar
• Benson AR, D'Angelica MI, Abbott DE, et al. NCCN guidelines insights: hepatobiliary cancers, version 1.2017. J Natl Compr Canc Netw. 2017;15(5):563–573.
   PubMed Web of Science ®Google Scholar
• Sapisochin G, Bruix J. Liver transplantation for hepatocellular carcinoma: outcomes and novel surgical approaches. Nat Rev Gastroenterol Hepatol. 2017;14(4):203–217.
   PubMed Web of Science ®Google Scholar
• Feng K, Yan J, Li X, et al. A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma. J Hepatol. 2012;57(4):794–802.
   PubMed Web of Science ®Google Scholar
• Johnson PJ, Berhane S, Kagebayashi C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol. 2015;33(6):550–558.
   PubMed Web of Science ®Google Scholar
• Abe T, Tashiro H, Kobayashi T, et al. Glasgow Prognostic Score and prognosis after hepatectomy for hepatocellular carcinoma. World J Surg. 2017;41(7):1860–1870.
   PubMed Web of Science ®Google Scholar
• Chen TM, Lin CC, Huang PT, et al. Neutrophil-to-lymphocyte ratio associated with mortality in early hepatocellular carcinoma patients after radiofrequency ablation. J Gastroenterol Hepatol. 2012;27(3):553–561.
   PubMed Web of Science ®Google Scholar
• Man Z, Pang Q, Zhou L, et al. Prognostic significance of preoperative prognostic nutritional index in hepatocellular carcinoma: a meta-analysis. HPB (Oxford)). 2018;20(10):888–895.
   PubMed Web of Science ®Google Scholar
• Sanghera C, Teh JJ, Pinato DJ. The systemic inflammatory response as a source of biomarkers and therapeutic targets in hepatocellular carcinoma. Liver Int. 2019;39(11):2008–2023.
   PubMed Web of Science ®Google Scholar
• Shibata T, Iimuro Y, Yamamoto Y, et al. Small hepatocellular carcinoma: comparison of radio-frequency ablation and percutaneous microwave coagulation therapy. Radiology. 2002;223(2):331–337.
   PubMed Web of Science ®Google Scholar
• Tan W, Deng Q, Lin S, et al. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis. Int J Hyperthermia. 2019;36(1):264–272.
   PubMed Web of Science ®Google Scholar
• Kudo M. Local ablation therapy for hepatocellular carcinoma: current status and future perspectives. J Gastroenterol. 2004;39(3):205–214.
   PubMed Web of Science ®Google Scholar
• Kaiser HF. The varimax criterion for analytic rotation in factor analysis. Psychometrika. 1958;23(3):187–200.
   Web of Science ®Google Scholar
• Ward JH. Hierarchical grouping to optimize an objective function. J Am Stat Assoc. 1963;58(301):236–244.
   Web of Science ®Google Scholar
• Vergara VM, Salman M, Abrol A, et al. Determining the number of states in dynamic functional connectivity using cluster validity indexes. J Neurosci Methods. 2020;337:108651.
   PubMed Web of Science ®Google Scholar
• Badagliacca R, Rischard F, Papa S, et al. Clinical implications of idiopathic pulmonary arterial hypertension phenotypes defined by cluster analysis. J Heart Lung Transplant. 2020;39(4):310–320.
   PubMed Web of Science ®Google Scholar
• Neudecker H, Greenacre M, Blasius J. Multiple correspondence analysis and related methods. Stat Papers. 2010;51(4):1017–1018.
   Google Scholar
• Rodriguez-Alvarez MX, Meira-Machado L, Abu-Assi E, et al. Nonparametric estimation of time-dependent ROC curves conditional on a continuous covariate. Stat Med. 2016;35(7):1090–1102.
   PubMed Web of Science ®Google Scholar
• Chu MO, Shen CH, Chang TS, et al. Pretreatment inflammation-based markers predict survival outcomes in patients with early stage hepatocellular carcinoma after radiofrequency ablation. Sci Rep. 2018;8(1):16611.
   PubMed Web of Science ®Google Scholar
• Zhang H, Han J, Xing H, et al. Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: a multicenter study. Surgery. 2019;165(3):516–524.
   PubMed Web of Science ®Google Scholar
• Zhang F, Wu G, Sun H, et al. Radiofrequency ablation of hepatocellular carcinoma in elderly patients fitting the Milan criteria: a single centre with 13 years experience. Int J Hyperthermia. 2014;30(7):471–479.
   PubMed Web of Science ®Google Scholar
• Hocquelet A, Balageas P, Laurent C, et al. Radiofrequency ablation versus surgical resection for hepatocellular carcinoma within the Milan criteria: a study of 281 Western patients. Int J Hyperthermia. 2015;31(7):749–757.
   PubMed Web of Science ®Google Scholar
• Doyle A, Gorgen A, Muaddi H, et al. Outcomes of radiofrequency ablation as first-line therapy for hepatocellular carcinoma less than 3cm in potentially transplantable patients. J Hepatol. 2019;70(5):866–873.
   PubMed Web of Science ®Google Scholar
• Ho SY, Liu PH, Hsu CY, et al. An albumin-bilirubin (ALBI) grade-based prognostic model for patients with hepatocellular carcinoma within milan criteria. Am J Clin Oncol. 2019;42:698–704.
   PubMed Web of Science ®Google Scholar
• Jiang YQ, Wang ZX, Deng YN, et al. Efficacy of hepatic resection vs. radiofrequency ablation for patients with very-early-stage or early-stage hepatocellular carcinoma: a population-based study with stratification by age and tumor size. Front Oncol. 2019;9:113.
   PubMed Web of Science ®Google Scholar
• Abe T, Tashiro H, Hattori M, et al. Prediction of long-term survival by using the Glasgow Prognostic Score in patients with hepatocellular carcinoma after liver transplantation. Hepatol Res. 2016;46(7):622–633.
   PubMed Web of Science ®Google Scholar
• Hato T, Zhu AX, Duda DG. Rationally combining anti-VEGF therapy with checkpoint inhibitors in hepatocellular carcinoma. Immunotherapy. 2016;8(3):299–313.
   PubMed Web of Science ®Google Scholar
• Kusumanto YH, Dam WA, Hospers GA, et al. Platelets and granulocytes, in particular the neutrophils, form important compartments for circulating vascular endothelial growth factor. Angiogenesis. 2003;6(4):283–287.
   PubMedGoogle Scholar
• Carlson CS, Aldred SF, Lee PK, et al. Polymorphisms within the C-reactive protein (CRP) promoter region are associated with plasma CRP levels. Am J Hum Genet. 2005;77(1):64–77.
   PubMed Web of Science ®Google Scholar